Sandoz Group AG

Swiss Stock Exchange SDZ.SW

Sandoz Group AG Goodwill for the year ending December 31, 2023: USD 6.39 B

Sandoz Group AG Goodwill is USD 6.39 B for the year ending December 31, 2023, a -7.17% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Sandoz Group AG Goodwill for the year ending December 31, 2022 was USD 6.88 B, a -1.71% change year over year.
  • Sandoz Group AG Goodwill for the year ending December 31, 2021 was USD 7.00 B, a -0.05% change year over year.
  • Sandoz Group AG Goodwill for the year ending December 31, 2020 was USD 7.00 B.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
SV Wall Street
Swiss Stock Exchange: SDZ.SW

Sandoz Group AG

CEO Mr. Richard Saynor
IPO Date Oct. 3, 2023
Location Switzerland
Headquarters Suurstoffi 14
Employees 22,633
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Plastics Vaccines
Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

StockViz Staff

February 7, 2025

Any question? Send us an email